Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices: JACC Review Topic of the Week

J Am Coll Cardiol. 2022 Jan 25;79(3):299-308. doi: 10.1016/j.jacc.2021.11.017.

Abstract

Cardiac implantable electronic device implantation rates have increased in recent decades. Venous obstruction of the subclavian, brachiocephalic, or superior vena cava veins represents an important complication of implanted leads. These forms of venous obstruction can result in significant symptoms as well as present a barrier to the implantation of additional device leads. The risk factors for the development of these complications remain poorly understood, and diagnosis relies on clinical recognition and cross-sectional imaging. Anticoagulation remains the mainstay of treatment, and thrombus debulking, lead extraction, venoplasty, and stenting are all important therapeutic interventions. This review provides a multidisciplinary-based approach to the evaluation and management of cardiac implantable electronic device lead-associated venous obstruction.

Keywords: cardiac implantable electronic device; superior vena cava syndrome; venous obstruction.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Defibrillators, Implantable / adverse effects*
  • Diagnostic Imaging
  • Humans
  • Pacemaker, Artificial / adverse effects*
  • Risk Factors
  • Thrombolytic Therapy
  • Vascular Diseases / etiology*
  • Vascular Diseases / therapy
  • Veins / diagnostic imaging